Index | RUT |
P/E | 152.23 |
EPS (ttm) | 0.65 |
Insider Own | 3.22% |
Shs Outstand | 5.52M |
Perf Week | -6.26% |
Market Cap | 542.98M |
Forward P/E | 11.54 |
EPS next Y | 8.52 |
Insider Trans | 3.56% |
Shs Float | 5.35M |
Perf Month | 20.22% |
Enterprise Value | 684.02M |
PEG | - |
EPS next Q | 2.08 |
Inst Own | 92.73% |
| |
Perf Quarter | 20.26% |
Income | 3.73M |
P/S | 2.19 |
EPS this Y | -13.42% |
Inst Trans | -7.88% |
| |
Perf Half Y | 24.91% |
Sales | 247.54M |
P/B | 2.91 |
EPS next Y | -6.07% |
ROA | 0.86% |
| |
Perf YTD | 25.20% |
Book/sh | 33.79 |
P/C | 18.74 |
EPS next 5Y | - |
ROE | 2.18% |
52W High | 131.20 -25.09% |
Perf Year | -15.63% |
Cash/sh | 5.25 |
P/FCF | 14.31 |
EPS past 3/5Y | - - |
ROIC | 1.07% |
52W Low | 55.45 77.24% |
Perf 3Y | -40.57% |
| |
EV/EBITDA | 16.19 |
Sales past 3/5Y | 9.34% 15.41% |
Gross Margin | 54.69% |
Volatility | 4.69% 4.22% |
Perf 5Y | -61.48% |
| |
EV/Sales | 2.76 |
EPS Y/Y TTM | 101.44% |
Oper. Margin | 6.96% |
ATR (14) | 4.20 |
Perf 10Y | -2.98% |
| |
Quick Ratio | 1.45 |
Sales Y/Y TTM | 4.12% |
Profit Margin | 1.51% |
RSI (14) | 57.54 |
| |
| |
Current Ratio | 1.94 |
EPS Q/Q | 311.31% |
SMA20 | 2.22% |
Beta | 0.93 |
| |
| |
Debt/Eq | 0.91 |
Sales Q/Q | 3.64% |
SMA50 | 8.69% |
Rel Volume | 0.70 |
Prev Close | 97.96 |
Employees | 730 |
LT Debt/Eq | 0.86 |
| |
SMA200 | 24.31% |
Avg Volume | 110.93K |
Price | 98.28 |
IPO | Feb 29, 1984 |
Option/Short | No / Yes |
| |
Trades | |
Volume | 76,503 |
Change | 0.33% |
|
 |
|
|
 |
|  |
| Date |
Action |
Analyst |
Rating Change |
Price Target Change |
| Aug-07-25 | Upgrade |
Wells Fargo |
Underweight → Equal Weight |
$67 |
| Aug-28-24 | Initiated |
Wells Fargo |
Underweight |
$120 |
| Jan-04-24 | Upgrade |
Evercore ISI |
In-line → Outperform |
$100 → $125 |
| Jan-04-21 | Downgrade |
Evercore ISI |
Outperform → In-line |
$300 |
| Nov-10-20 | Initiated |
KeyBanc Capital Markets |
Sector Weight |
$287 |
| Oct-02-20 | Initiated |
JP Morgan |
Neutral |
$260 |
| Dec-04-19 | Initiated |
Jefferies |
Buy |
|
| Aug-26-19 | Initiated |
Evercore ISI |
Outperform |
$250 |
| Jun-10-16 | Downgrade |
Sidoti |
Buy → Neutral |
|
|
 |
|
Apr-02-26 06:00PM
|
|
|
Mar-09-26 04:30PM
|
|
|
Feb-20-26 07:02AM
|
|
|
Feb-03-26 08:11AM
|
(Associated Press Finance)
+8.73%
|
|
08:00AM
|
|
| 05:00PM |
Loading… |
|
Jan-07-26 05:00PM
|
|
|
Dec-18-25 07:00PM
|
|
|
Dec-03-25 05:35PM
|
|
|
Nov-25-25 08:09AM
|
|
|
Nov-12-25 03:14PM
|
|
|
Nov-06-25 07:01PM
|
(Associated Press Finance)
|
|
04:15PM
|
|
|
Oct-03-25 11:46AM
|
|
|
11:01AM
|
|
|
Sep-22-25 06:53AM
|
|
| 06:34PM |
Loading… |
|
Sep-05-25 06:34PM
|
|
|
Aug-18-25 02:01PM
|
|
|
Aug-05-25 09:15AM
|
|
|
08:10AM
|
(Associated Press Finance)
|
|
08:00AM
|
|
|
Jul-31-25 05:45PM
|
|
|
Jul-03-25 12:00PM
|
|
|
Jul-02-25 03:20PM
|
|
|
May-28-25 09:15AM
|
|
|
08:23AM
|
(Associated Press Finance)
|
|
08:00AM
|
|
|
May-15-25 05:25PM
|
|
|
May-14-25 05:45PM
|
|
|
May-13-25 05:35PM
|
|
|
May-08-25 08:45AM
|
|
| 03:00PM |
Loading… |
|
Apr-07-25 03:00PM
|
|
|
Apr-03-25 03:51PM
|
|
|
Mar-26-25 12:00PM
|
|
|
Feb-13-25 08:31AM
|
|
|
Feb-11-25 12:20PM
|
|
|
Feb-04-25 09:15AM
|
|
|
08:17AM
|
(Associated Press Finance)
|
|
08:00AM
|
|
|
Jan-17-25 01:15PM
|
|
|
Jan-06-25 03:00PM
|
|
|
Nov-07-24 09:20AM
|
|
|
08:27AM
|
(Associated Press Finance)
|
|
08:00AM
|
|
|
Oct-15-24 05:02PM
|
|
|
Oct-02-24 02:00PM
|
|
|
Aug-26-24 12:20PM
|
|
|
12:00PM
|
|
|
Aug-16-24 07:51AM
|
|
|
Aug-05-24 08:15AM
|
(Associated Press Finance)
|
|
08:00AM
|
|
|
Jul-31-24 09:14AM
|
|
|
Jul-08-24 02:00PM
|
|
|
Jun-05-24 11:53AM
|
|
|
06:38AM
|
|
|
06:21AM
|
(Associated Press Finance)
|
|
06:00AM
|
|
|
May-31-24 06:00AM
|
|
|
May-22-24 06:00AM
|
|
|
Apr-08-24 08:00AM
|
|
|
Apr-04-24 06:24PM
|
|
|
Apr-01-24 10:27AM
|
|
|
Mar-15-24 07:00AM
|
|
|
Feb-19-24 10:23AM
|
|
|
Feb-05-24 09:20AM
|
|
|
08:36AM
|
|
|
08:22AM
|
(Associated Press Finance)
|
|
08:00AM
|
|
|
Jan-08-24 08:00AM
|
|
|
Jan-04-24 03:00PM
|
|
|
Jan-03-24 08:00AM
|
|
|
Dec-14-23 10:47AM
|
|
|
Nov-06-23 09:10AM
|
|
|
08:13AM
|
(Associated Press Finance)
|
|
08:00AM
|
|
|
Oct-16-23 03:00AM
|
|
|
Oct-03-23 08:00AM
|
|
|
Sep-22-23 08:09AM
|
|
|
06:20AM
|
|
|
Sep-15-23 01:10AM
|
|
|
Sep-13-23 01:37PM
|
|
|
Sep-11-23 11:21AM
|
|
|
Aug-24-23 04:02PM
|
|
|
Aug-10-23 01:32AM
|
|
|
Aug-03-23 09:35AM
|
|
|
08:27AM
|
|
|
08:00AM
|
|
|
Jul-31-23 07:50AM
|
|
|
Jul-05-23 03:00PM
|
|
|
Jun-21-23 08:00PM
|
|
|
11:50AM
|
|
|
May-25-23 09:25AM
|
|
|
08:14AM
|
|
|
08:00AM
|
|
|
May-22-23 01:16PM
|
|
|
May-02-23 06:23AM
|
|
|
Apr-26-23 08:00PM
|
|
|
Apr-03-23 06:15PM
|
|
|
06:00PM
|
|
|
07:42AM
|
|
|
Mar-13-23 08:00AM
|
|
|
|
|
 |
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Clinical Genomics segment division develops, manufactures and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables and services that enable clinical research labs and contract research organizations. The Biopharmaceutical Development segment caters and sells automated systems for protein analysis and peptide synthesis solutions. The Calibration Solutions segment focuses on the quality control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications such as renal care, environmental and process monitoring, gas flow, air quality and torque testing, primarily in medical device manufacturing, pharmaceutical manufacturing, laboratory and hospital environments. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO. |  |
|
|
 |
|  |
|
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Ladiwala Shiraz Shabanali | Director | Mar 10 '26 | Buy | 72.23 | 3,500 | 252,805 | 8,523 | Mar 10 05:43 PM | | Capone Mark Christopher | Director | Mar 10 '26 | Buy | 76.35 | 1,301 | 99,331 | 3,429 | Mar 10 03:46 PM | | Tripeny R Tony | Director | Mar 10 '26 | Buy | 76.00 | 1,315 | 99,940 | 5,398 | Mar 10 03:39 PM | | Owens Gary M | President and CEO | Oct 27 '25 | Option Exercise | 0.00 | 11,558 | 0 | 64,135 | Oct 28 03:08 PM | | Ladiwala Shiraz Shabanali | Director | Aug 15 '25 | Option Exercise | 0.00 | 1,949 | 0 | 5,023 | Aug 18 02:37 PM | | Sullivan John James | Director | Aug 15 '25 | Option Exercise | 0.00 | 1,404 | 0 | 27,282 | Aug 18 02:20 PM | | Hall Shannon | Director | Aug 15 '25 | Option Exercise | 0.00 | 1,404 | 0 | 4,189 | Aug 18 02:02 PM | | Tripeny R Tony | Director | Aug 15 '25 | Option Exercise | 0.00 | 1,404 | 0 | 4,083 | Aug 18 01:54 PM | | Capone Mark Christopher | Director | Aug 15 '25 | Option Exercise | 0.00 | 1,404 | 0 | 2,128 | Aug 18 01:45 PM | | Alltoft Jennifer Sadie | Director | Aug 15 '25 | Option Exercise | 0.00 | 1,404 | 0 | 4,878 | Aug 18 01:34 PM | | Sakys John | CFO | Jun 21 '25 | Option Exercise | 95.82 | 1,036 | 99,270 | 15,498 | Jun 25 09:14 AM | | Archbold Brian David | SVP Operations | Jun 21 '25 | Option Exercise | 95.82 | 844 | 80,872 | 2,792 | Jun 25 09:05 AM | | Owens Gary M | President and CEO | Jun 21 '25 | Option Exercise | 95.82 | 3,301 | 316,302 | 54,022 | Jun 24 10:12 AM | | Owens Gary M | President and CEO | Jun 18 '25 | Option Exercise | 92.99 | 8,707 | 809,664 | 54,531 | Jun 20 05:39 PM | | Archbold Brian David | SVP Operations | Jun 18 '25 | Option Exercise | 92.99 | 2,556 | 237,682 | 3,114 | Jun 20 05:31 PM | | Sakys John | CFO | Jun 18 '25 | Option Exercise | 92.99 | 2,840 | 264,092 | 15,705 | Jun 20 05:22 PM | | Owens Gary M | President and CEO | Jun 15 '25 | Option Exercise | 0.00 | 4,426 | 0 | 47,763 | Jun 18 11:27 AM | | Owens Gary M | President and CEO | Jun 16 '25 | Sale | 97.12 | 1,939 | 188,312 | 45,824 | Jun 18 11:27 AM | | Archbold Brian David | SVP Operations | Jun 15 '25 | Option Exercise | 0.00 | 1,030 | 0 | 1,030 | Jun 18 11:13 AM | | Archbold Brian David | SVP Operations | Jun 16 '25 | Sale | 97.12 | 472 | 45,840 | 558 | Jun 18 11:13 AM | | Sakys John | CFO | Jun 15 '25 | Option Exercise | 0.00 | 793 | 0 | 12,839 | Jun 18 10:59 AM | | Sakys John | CFO | Jun 16 '25 | Sale | 97.12 | 642 | 62,350 | 12,865 | Jun 18 10:59 AM | | Archbold Brian David | Officer | Jun 16 '25 | Proposed Sale | 97.12 | 472 | 45,840 | | Jun 16 03:49 PM | | Owens Gary M | Officer | Jun 16 '25 | Proposed Sale | 97.12 | 1,939 | 188,311 | | Jun 16 03:47 PM | | Sakys John | Officer | Jun 16 '25 | Proposed Sale | 97.12 | 642 | 62,350 | | Jun 16 03:40 PM |
|
|